Brucella abortus Antibodies

Santa Cruz Biotechnology offers a broad range of Brucella abortus monoclonal antibodies for research focused on understanding this significant pathogen. Brucella abortus Antibodies targeting Brucella abortus are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Brucella abortus is a bacterium responsible for brucellosis, a zoonotic infection that poses serious health risks to both animals and humans. Understanding the immune response to Brucella abortus is crucial for developing effective vaccines and treatments, as well as for controlling outbreaks in livestock. The study of Brucella abortus is essential for public health, agriculture, and veterinary medicine. Research into Brucella abortus pathogenesis has revealed complex mechanisms of host cell invasion and immune evasion. Investigating the molecular interactions between Brucella abortus and host cells provides insights into bacterial survival strategies and potential therapeutic targets. Current research focuses on identifying key virulence factors and understanding host immune responses. Santa Cruz Biotechnology monoclonal antibodies targeting Brucella abortus support researchers worldwide in advancing scientific understanding of this important pathogen and developing new therapeutic strategies.